Surat, October 28, 2022: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical players, has announced its financial results for the quarter ended September 30, 2022.
Standalone Financial Highlights for the Quarter Ended September 30th, 2022:
Operating Revenues at ₹3,107 million in Q2FY23 as compared to ₹2,489 million in Q2FY22 – growth of 25% Y-o-Y.
Total Revenues at ₹3,087 million in Q2FY23 as compared to ₹2,552 million in Q2FY22 – growth of 21% Y-o-Y.
EBITDA (incl. other revenue) at ₹898 million in Q2FY23 as compared to ₹697 million in Q2FY22 – growth of 29% Y-o-Y.
Profit After Tax at ₹412 million in Q2FY23 as compared to ₹358 million in Q2FY22 – growth of 15% Y-o-Y.
Anand Desai, Managing Director of Anupam Rasayan, commented, “I am delighted to inform you that our standalone business grew by 25% year on year to Rs. 310cr. with consistent EBITDA margins.
Our philosophy of carrying a long-term vision in our business conduct is bearing its fruits as Anupam has started seeing the benefits of this Europe+1 trend with our latest announcement of signing two contracts with one of the European Crop Protection company for supplying two new life science-related specialty chemicals.
Overall, we continue to see upward bias in all the contracted volumes with major customers. This makes us confident of delivering a strong performance in the coming quarters and for the year.”
